Peptides AcademyUse Cases
Representative peptide use-case studies.
Representative peptide use-case studies — each outlines a candidate profile, protocol, expected trajectory, and monitoring framework for a specific therapeutic goal.
Desmopressin for Central Diabetes Insipidus: Replacing the Missing Antidiuretic Hormone
In central diabetes insipidus the body can't make enough vasopressin, so it loses water uncontrollably. Desmopressin, a V2-selective vasopressin analog, replaces the missing signal — with hyponatremia as the key safety concern.
Difelikefalin for Dialysis Itch: Kappa-Opioid Relief Without the Opioid Baggage
Chronic kidney disease itch is common, severe, and under-treated. Difelikefalin, a peripherally-restricted kappa-opioid peptide, dampens the itch pathway and is dosed conveniently into the dialysis circuit — without opioid-like risks.
Icatibant for Hereditary Angioedema Attacks: Blocking Bradykinin at the Source of Swelling
Hereditary angioedema attacks are driven by bradykinin, not histamine, so allergy drugs fail. Icatibant blocks the bradykinin B2 receptor and can be self-injected at home at the first sign of an attack.
Terlipressin for Hepatorenal Syndrome: Fixing the Circulation to Rescue the Kidneys
In hepatorenal syndrome, structurally normal kidneys fail because cirrhosis dilates the gut circulation. Terlipressin, a long-acting vasopressin analog given with albumin, constricts those vessels and can reverse the kidney failure.
Vosoritide for Children with Achondroplasia: Targeting the FGFR3 Brake on Growth
Achondroplasia slows bone growth because overactive FGFR3 brakes the growth plate. Vosoritide, a stabilized CNP analog, restores the opposing signal to increase growth velocity in children with open growth plates.
Ziconotide for Refractory Chronic Pain: A Non-Opioid Option Delivered to the Spine
For severe pain that resists other treatments, ziconotide — a synthetic cone-snail venom peptide — blocks N-type calcium channels in the spinal cord, relieving pain without opioid tolerance or dependence, but with a narrow safety window.
Apraglutide for Short Bowel Syndrome: A Weekly GLP-2 Approach to Intestinal Failure
Apraglutide is a long-acting GLP-2 analog developed for short bowel syndrome, designed for once-weekly dosing. How GLP-2 grows the remaining intestine, why weekly dosing matters, and why this is specialist-managed rather than self-directed.
Calcitonin for Acute Vertebral Fracture Pain: A Short-Term, Well-Defined Role
Salmon calcitonin has a genuine, if narrow, use: reducing the acute pain of a fresh vertebral compression fracture. Why it helps, why it is used only short-term, and why it is not a long-term osteoporosis treatment.
Cenegermin for Neurotrophic Keratitis: Treating the Cause, Not Just the Surface
Cenegermin is a recombinant human NGF eye drop, the first approved therapy that targets the nerve damage underlying neurotrophic keratitis. How it restores corneal healing, how it is used, and why it needs specialist care.
Teriparatide for Severe Osteoporosis: Building Bone, Not Just Slowing Loss
Teriparatide is an anabolic PTH(1-34) peptide that actively builds new bone, reserved for high-risk osteoporosis. Who it fits, why it is dosed daily, how it differs from bisphosphonates, and why what comes after it matters as much as the drug itself.
VK2735 for Weight Loss: A Dual GIP/GLP-1 Agonist in Oral and Injectable Development
VK2735 is an investigational dual GIP/GLP-1 agonist from Viking Therapeutics, developed in both injectable and oral forms. What the early data suggest, how it fits among next-generation obesity drugs, and why it remains a science-to-watch story.
Amycretin for Oral Weight Loss: Promise and Limits of a GLP-1/Amylin Co-Agonist
Amycretin is an investigational GLP-1/amylin co-agonist being developed in both oral and injectable forms, with early trials showing striking weight loss. What the data suggest, why an oral peptide is notable, and why this is a science-to-watch story rather than an available treatment.
Davunetide for Cognitive Neuroprotection: A Cautionary Tale in Tauopathy Research
Davunetide (NAP) is a microtubule-stabilizing peptide once hoped to protect against tau-driven neurodegeneration. Its pivotal trial failure and narrower revival illustrate why a sound mechanism doesn't guarantee clinical benefit — and why it's not a nootropic.
MariTide for Obesity: The Case for Monthly Dosing and a Contrarian GIP Strategy
MariTide (maridebart cafraglutide) is Amgen's investigational obesity drug notable for two things: dosing as infrequently as monthly, and blocking GIP while activating GLP-1 — the opposite of tirzepatide. What that means, what the data suggest, and why it remains investigational.
GHK-Cu for Keloid & Scar Support
An honest look at GHK-Cu and keloid scars — why the copper-peptide skin-remodeling rationale is weak in this specific setting, why keloids behave unlike ordinary wounds, and why established care (steroid injection, silicone, surgery plus radiation) remains primary.
Tesamorelin for HIV-Associated Lipodystrophy
A use case grounded in an actual approved indication: tesamorelin, a GHRH analog FDA-approved to reduce excess visceral fat in HIV-associated lipodystrophy. The mechanism, what the label supports, why the effect reverses on discontinuation, and the IGF-1 monitoring that comes with it.
Thymosin Beta-4 for Dry Eye Disease
A use case with a real research signal: thymosin beta-4 eye drops have been studied in dry-eye disease and neurotrophic keratitis for their corneal wound-healing rationale. What the trial-stage evidence supports, what remains unproven, and why this is investigational rather than a product you should self-source.
BPC-157 for Golfer's Elbow (Medial Epicondylitis)
A representative use case for BPC-157 as an adjunct in medial epicondylitis — the tendinopathy healing rationale, why progressive loading remains the primary treatment, and how localized peptide use is positioned in anecdotal protocols.
BPC-157 for Meniscus Injury Support
A representative use case exploring BPC-157 as an adjunct in meniscus injury recovery — the connective-tissue healing rationale, why the meniscus blood-supply problem limits expectations, and how it sits alongside rehabilitation and surgical care.
DSIP for Jet Lag and Circadian Sleep Disruption
A representative use case examining DSIP for circadian sleep disruption and jet lag — the sleep-modulation rationale, the limited and dated evidence base, and why timed light and melatonin remain first-line.
TB-500 for Hamstring Strain Recovery
A representative use case for TB-500 as an adjunct in hamstring strain recovery — the cell-migration and remodeling rationale, why eccentric strengthening prevents re-injury, and anti-doping considerations for athletes.
Cerebrolysin for TBI Neuroprotection
Cerebrolysin is a porcine brain-derived peptide preparation studied extensively for neuroprotection after traumatic brain injury. Learn about the clinical evidence, protocols, and monitoring considerations.
Selank Intranasal for Social Anxiety
Selank is a synthetic peptide with anxiolytic properties studied primarily in Russia for generalized and social anxiety. Learn about its mechanism, intranasal protocol, and evidence base.
SS-31 for Cardiac Aging and Mitochondrial Dysfunction
SS-31 (elamipretide) is a mitochondria-targeted peptide being investigated for age-related cardiac decline. Learn about its mechanism, clinical evidence in heart failure, and monitoring considerations.
Thymosin Alpha-1 as Hepatitis B Adjunct Therapy
Thymosin alpha-1 (Zadaxin) has been studied as an adjunct therapy for chronic hepatitis B, enhancing immune response against the virus. Learn about the clinical evidence and treatment protocols.
VIP for CIRS and Mold Illness
Vasoactive intestinal peptide (VIP) is used in the Shoemaker protocol as a final step in treating chronic inflammatory response syndrome (CIRS) from mold exposure. Learn about the evidence and protocol details.
BPC-157 for Achilles Tendinopathy
A representative use case for BPC-157 in chronic Achilles tendinopathy — VEGF upregulation and tendon fibroblast mechanisms, peritendinous injection and oral protocol, eccentric loading integration, and preclinical evidence assessment.
Cerebrolysin for Parkinson's Disease Neuroprotection
A representative use case for Cerebrolysin as adjunctive neuroprotective therapy in early-to-moderate Parkinson's disease — neurotrophic factor mimicry, dopaminergic neuron protection, IV protocol design, and clinical trial evidence.
GHK-Cu for Alopecia Areata
A representative use case for GHK-Cu copper peptide in alopecia areata — Wnt/beta-catenin pathway activation, follicle neogenesis mechanism, topical scalp protocol, regrowth timeline, and honest assessment of preclinical versus clinical evidence.
KPV for Ulcerative Colitis Inflammation
A representative use case for KPV tripeptide in ulcerative colitis — NF-kB inhibition mechanism, oral delivery protocol, combination approach with BPC-157, fecal calprotectin monitoring, and honest assessment of preclinical versus clinical evidence.
MOTS-c for Age-Related Insulin Resistance
A representative use case for MOTS-c in age-related insulin resistance — mitochondrial-derived peptide mechanism via AMPK activation, subcutaneous protocol design, first-in-human trial data, and the rationale for replacement of declining endogenous levels.
Retatrutide for Severe Obesity and Metabolic Syndrome
A representative use case for retatrutide in severe obesity and metabolic syndrome — the triple GIP/GLP-1/glucagon receptor agonist mechanism, 24-week dose escalation protocol, and assessment of the Phase 2 data showing 24.2% body weight loss.
Selank for Generalized Anxiety Disorder
A representative use case for Selank in generalized anxiety disorder — GABA-A receptor modulation, enkephalinase inhibition, intranasal protocol design, and an honest assessment of the Russian clinical evidence without Western RCT confirmation.
Semaglutide for NAFLD/NASH
A representative use case for semaglutide in non-alcoholic fatty liver disease and steatohepatitis — GLP-1 receptor-mediated hepatic fat reduction, protocol escalation from 0.25 mg to 2.4 mg weekly, and assessment of the strong Phase 2 clinical evidence.
Thymosin Alpha-1 for Chronic Lyme Immune Support
A representative use case for Thymosin alpha-1 in chronic Lyme disease immune support — dendritic cell maturation mechanism, Th1/Th2 balancing protocol, immune marker monitoring, and honest assessment of the limited but growing evidence base.
VIP for Mast Cell Activation Syndrome
A representative use case for vasoactive intestinal peptide in mast cell activation syndrome — VPAC1/VPAC2 receptor-mediated mast cell stabilization, intranasal Shoemaker protocol, and honest assessment of the clinical evidence base without RCT support.
BPC-157 for Post-ACL Reconstruction Recovery
A representative use case for BPC-157 following ACL reconstruction surgery — targeting graft healing, reducing post-surgical inflammation, and accelerating rehabilitation milestones within a structured recovery timeline.
Semaglutide for Non-Alcoholic Fatty Liver Disease (NAFLD)
A representative use case for semaglutide in NAFLD and NASH — leveraging GLP-1 receptor agonism to reduce hepatic steatosis, improve liver enzymes, and address the metabolic root causes of fatty liver disease.
Thymosin Alpha-1 for Chronic Mold Exposure Recovery
A representative use case for thymosin alpha-1 in patients recovering from chronic mold and mycotoxin exposure — addressing immune dysregulation, Th1/Th2 imbalance, and the persistent inflammatory response to biotoxin illness.
BPC-157 for Oral Ulcer & Mucosal Healing
A representative use case for BPC-157 in oral and mouth ulcer healing — topical and oral protocol design for recurrent aphthous ulcers, mucosal repair mechanisms, and realistic expectations from preclinical evidence.
BPC-157 for Post-Dental Surgery Recovery
A representative use case for oral BPC-157 following dental surgery — post-extraction healing, implant site recovery, and gum graft support through mucosal angiogenesis and VEGFR2 upregulation, with practical protocol design and honest evidence assessment.
GHK-Cu for Post-Chemical Peel Skin Recovery
A representative use case for topical GHK-Cu to accelerate skin recovery after medium-depth chemical peels (TCA, Jessner), leveraging fibroblast stimulation, collagen gene upregulation, and anti-inflammatory modulation to synergize with peel-induced dermal remodeling.
GHK-Cu After Microneedling for Collagen Induction
A representative use case for GHK-Cu applied after microneedling — leveraging microchannel-enhanced peptide delivery for collagen induction therapy, decorin-mediated fibril organization, and accelerated post-procedure recovery.
LL-37 for Chronic Sinusitis & Biofilm-Related Infections
A representative use case for intranasal LL-37 in chronic rhinosinusitis with nasal polyps — targeting Staphylococcus aureus biofilms through direct antimicrobial activity, biofilm disruption, and local immune recruitment as an adjunct to standard ENT care.
Selank for Exam & Test Performance Anxiety
A representative use case for Selank in managing test and exam anxiety — intranasal protocol for high-stakes academic and professional performance situations, GABA modulation without cognitive blunting, and combination with Semax for dual anxiolytic-nootropic support.
Semaglutide for PCOS Metabolic Management
A GLP-1 agonist approach for the metabolic phenotype of PCOS — targeting insulin resistance, visceral adiposity, and hepatic lipid accumulation with semaglutide, including differentiation from metformin and fertility discontinuation guidance.
Sermorelin for Age-Related Sleep Quality Decline
A representative use case for sermorelin to restore nocturnal GH pulsatility and improve slow-wave sleep architecture in adults 45 and older experiencing age-related sleep quality decline.
TB-500 for Post-Cardiac Event Tissue Repair
A representative use case for TB-500 (thymosin beta-4) in cardiac tissue repair after myocardial infarction — mechanism of cardiomyocyte protection, preclinical evidence for ventricular remodeling, and the substantial gap between animal data and clinical application.
Thymosin Alpha-1 as Adjunct to Cancer Immunotherapy
A representative use case for thymosin alpha-1 as an adjunctive agent alongside cancer immunotherapy — enhancing T-cell and dendritic cell function, clinical trial evidence in hepatocellular carcinoma and melanoma, and the critical distinction between adjunct support and primary treatment.
Thymosin Alpha-1 for Post-Chemotherapy Immune Recovery
A representative use case for thymosin alpha-1 (Zadaxin) in post-chemotherapy immune reconstitution — restoring lymphocyte populations through thymic output enhancement, T-cell maturation, and dendritic cell activation after chemotherapy-induced lymphodepletion.
BPC-157 for Achilles Tendon Injury
A specific use case for BPC-157 in Achilles tendinopathy and post-rupture recovery — addressing the unique biomechanics and healing challenges of the body's largest tendon.
GHK-Cu for Post-Laser Skin Recovery
GHK-Cu accelerates skin recovery after ablative laser procedures by stimulating collagen synthesis, promoting angiogenesis, and modulating inflammation — supporting both faster healing and better cosmetic outcomes.
Semaglutide for PCOS & Insulin Resistance
Semaglutide addresses the metabolic root of polycystic ovary syndrome by improving insulin sensitivity, reducing androgen levels, and promoting weight loss — the three pillars of PCOS management.
SS-31 for Age-Related Muscle Decline (Sarcopenia)
SS-31 (elamipretide) targets the inner mitochondrial membrane to restore bioenergetics in aging muscle — addressing the upstream cause of sarcopenia rather than just its symptoms.
Thymosin Alpha-1 for Chronic Hepatitis B
Thymosin alpha-1 is approved in over 35 countries as an immunomodulatory therapy for chronic hepatitis B, supporting HBe antigen seroconversion through T-cell enhancement rather than direct antiviral activity.
BPC-157 for IBS and Gut Healing
A representative use case for BPC-157 in irritable bowel syndrome — oral administration for mucosal healing, intestinal permeability restoration, dietary integration, and combination with larazotide and KPV.
Cerebrolysin for Post-Stroke Cognitive Recovery
A representative use case for Cerebrolysin in post-stroke cognitive recovery — neurotrophic mechanism, clinical trial evidence from the CASTA trial, IV administration protocol, and cognitive milestone tracking.
Epitalon for Age-Related Sleep Disruption
A representative use case for epitalon in age-related sleep disruption — pineal gland mechanism, 10-day cycle protocol, melatonin restoration, sleep quality monitoring, and combination with DSIP.
GHK-Cu for Post-Procedure Skin Recovery
A representative use case for GHK-Cu in post-procedure skin recovery — accelerating healing after microneedling, laser resurfacing, and chemical peels through gene expression modulation and matrix remodeling.
Larazotide for Celiac Disease and Gluten Exposure
A representative use case for Larazotide in celiac disease management — tight junction mechanism, AT-1001 clinical trial evidence, prophylactic use before gluten exposure, and the Phase 3 program.
MOTS-c for Insulin Resistance and Metabolic Optimization
A representative use case for MOTS-c in insulin resistance — the exercise-mimetic peptide's AMPK activation mechanism, metabolic protocol design, and HOMA-IR monitoring strategy.
Selank for Performance Anxiety
A representative use case for selank in performance anxiety — intranasal administration, GABA modulation, pre-event dosing strategy, and comparison with NA-Selank-Amidate for acute situational anxiety.
Semaglutide for PCOS-Related Weight Management
A representative use case for semaglutide in PCOS-related weight management — addressing insulin resistance, hyperandrogenism, and metabolic dysfunction through GLP-1 receptor agonism with structured titration.
TB-500 for Rotator Cuff Recovery
A representative use case for TB-500 in rotator cuff recovery — loading and maintenance phases, BPC-157 combination rationale, physical therapy integration, and imaging milestones for partial tears.
Thymosin Alpha-1 for Post-Viral Fatigue Recovery
A representative use case for Thymosin Alpha-1 in post-viral fatigue recovery — immune retraining after EBV, COVID, or other viral insults, T-cell rebalancing protocol, and monitoring strategy.
Cerebrolysin for Traumatic Brain Injury Recovery
A representative use case for Cerebrolysin in traumatic brain injury recovery — neurotrophic peptide mixture mechanism, intravenous and intramuscular protocols, expected neurological recovery timeline, and evidence from TBI clinical trials.
CJC-1295 DAC for Sustained Growth Hormone Elevation
A representative use case for CJC-1295 DAC in sustained growth hormone elevation — Drug Affinity Complex mechanism for extended half-life, weekly dosing protocol, expected IGF-1 timeline, and comparison with CJC-1295 no-DAC and secretagogue stacks.
GHRP-6 for GH Release & Appetite Stimulation
A representative use case for GHRP-6 in growth hormone secretion and appetite stimulation — ghrelin mimetic mechanism, pulse-based dosing protocol, expected GH elevation timeline, and considerations for individuals needing caloric surplus support.
HGH Fragment 176-191 for Targeted Fat Loss
A representative use case for HGH Fragment 176-191 in targeted fat loss — lipolytic mechanism without GH's metabolic side effects, fasted-state dosing protocol, expected body composition timeline, and comparison with AOD-9604.
IGF-1 LR3 for Muscle Hypertrophy & Site-Specific Growth
A representative use case for IGF-1 LR3 in muscle hypertrophy and site-specific growth — extended half-life IGF-1 analog mechanism, bilateral injection protocol, expected hypertrophy timeline, and evidence from preclinical and practitioner data.
Liraglutide for Weight Management & Glycemic Control
A representative use case for Liraglutide in weight management and glycemic control — GLP-1 receptor agonist mechanism, dose-titration protocol, expected weight loss timeline, and comparison with semaglutide and tirzepatide.
Matrixyl 3000 for Anti-Wrinkle Skin Rejuvenation
A representative use case for Matrixyl 3000 in anti-wrinkle skin rejuvenation — matrikine signaling mechanism, topical application protocol, expected wrinkle reduction timeline, and evidence from clinical dermatology studies.
Melanotan II for Tanning & Skin Pigmentation
A representative use case for Melanotan II in tanning and skin pigmentation — non-selective melanocortin receptor agonism, low-dose subcutaneous protocol, expected pigmentation timeline, and comprehensive risk assessment including nevi changes and off-target effects.
MGF (Mechano Growth Factor) for Muscle Repair & Recovery
A representative use case for MGF (Mechano Growth Factor) in post-exercise muscle repair — splice variant biology, intramuscular injection protocol for satellite cell activation, expected recovery timeline, and PEG-MGF comparison.
Thymalin for Age-Related Immune Restoration
A representative use case for Thymalin in age-related immune decline — thymic peptide bioregulation mechanism, cyclical injection protocol for T-cell restoration, expected immune marker timeline, and evidence from Russian gerontological research.
Melanotan I for UV Photoprotection
A representative use case for Melanotan I (afamelanotide) in UV photoprotection — melanocortin-1 receptor agonism to enhance melanogenesis, protocol design for photosensitive individuals, expected pigmentation timeline, and safety considerations.
Selank for Social Anxiety & Stress Resilience
A representative use case for Selank in social anxiety and stress resilience — intranasal protocol targeting BDNF upregulation and enkephalin modulation, expected timeline, and combination with Semax for cognitive-emotional balance.
Semaglutide for Metabolic Syndrome Management
A representative use case for semaglutide in metabolic syndrome — multi-parameter improvement across insulin resistance, visceral adiposity, dyslipidemia, and cardiovascular risk through GLP-1 receptor agonism.
TB-500 for Tendon & Ligament Repair
A representative use case for TB-500 in chronic tendinopathy and ligament injury — loading and maintenance protocol, actin-sequestration mechanism for connective tissue, expected timeline, and combination with BPC-157.
VIP for Chronic Inflammatory Conditions
A representative use case for Vasoactive Intestinal Peptide (VIP) in chronic systemic inflammation — VPAC receptor-mediated immune modulation, protocol design for CIRS and inflammatory conditions, and combination with KPV and LL-37.
Argireline for Expression Line Reduction
A representative use case for Argireline (Acetyl Hexapeptide-3) in expression line reduction — topical application protocol, mechanism of action, expected timeline, and realistic expectations versus injectable neurotoxins.
Cartalax Bioregulator for Neuroprotective Aging
A representative use case for Cartalax (Ala-Glu-Asp) as a bioregulator peptide for neuroprotective aging — oral administration, cycled protocol, cartilage and neurological rationale, and the Khavinson bioregulator evidence base.
Ipamorelin for Anti-Aging Growth Hormone Optimization
A representative use case for Ipamorelin targeting age-related growth hormone decline — selective GH secretagogue protocol, anti-aging rationale, expected body composition and recovery benefits, and the distinction from exogenous GH.
Kisspeptin-10 for Fertility & Hormonal Support
A representative use case for Kisspeptin-10 in fertility and hormonal support — mechanism of GnRH stimulation, clinical evidence from IVF trials, subcutaneous protocol, and the distinction between clinical research and investigational use.
Livagen Bioregulator for Liver Support & Hepatoprotection
A representative use case for Livagen (Lys-Glu-Asp-Trp) as a liver bioregulator — hepatoprotective mechanism, cycled oral protocol, liver function monitoring, and the bioregulator evidence base for organ-specific support.
GHK-Cu for Hair Restoration
A representative use case for GHK-Cu in hair restoration — gene expression effects on follicle stem cells, Wnt pathway activation, comparison with minoxidil, and topical application protocols.
MK-677 (Ibutamoren) for Sleep Enhancement
A representative use case for MK-677 (ibutamoren) as a sleep-quality enhancer — deep sleep augmentation via the GH-ghrelin axis, clinical trial evidence, dosing for sleep vs. body composition, and side effects to monitor.
Larazotide for Leaky Gut & Intestinal Permeability
A representative use case for larazotide acetate in intestinal permeability (leaky gut) — zonulin pathway mechanism, celiac disease trial data, broader IBS and permeability applications, and protocol considerations.
BPC-157 for Gut Healing & Leaky Gut
A representative use case for BPC-157 in gut healing — intestinal barrier restoration, mucosal repair, protocol design for increased intestinal permeability, and combination strategies with KPV.
Oxytocin for Social Anxiety & Bonding
A representative use case for intranasal oxytocin in social anxiety and interpersonal bonding — mechanism, protocol considerations, evidence from autism and social anxiety research, and important limitations.
Thymulin for Immune Aging & Thymic Involution
A representative use case for thymulin in age-related immune decline — addressing thymic involution, declining T-cell diversity, and immunosenescence through thymic peptide supplementation.
Epithalon for Telomere Maintenance & Longevity
A representative use case for Epithalon in telomere maintenance — candidate profile, cycling protocol, biomarker monitoring, and realistic expectations for longevity applications.
KPV for Inflammatory Bowel Conditions
A representative use case for KPV in inflammatory bowel conditions — mechanism targeting NF-κB, oral delivery considerations, protocol design, and combination with BPC-157 for comprehensive gut healing.
Pinealon for Age-Related Cognitive Support
A representative use case for Pinealon in age-related cognitive support — candidate profile, bioregulator cycling protocol, combination with other nootropic peptides, and monitoring approach.
Tesofensine for Stubborn Weight Management
A representative use case for tesofensine in weight management — candidate profile for GLP-1 non-responders or those who cannot tolerate incretin therapy, protocol design, cardiovascular monitoring, and realistic expectations.
Oral Collagen Peptides for Skin Hydration & Elasticity
A representative use case for oral collagen peptides in skin hydration and elasticity — candidate profile, supplementation protocol, expected timeline, and what the meta-analyses actually show.
NA-Selank Amidate for Focus & Cognitive Clarity
A representative use case for NA-Selank Amidate as a daily nootropic — candidate profile, intranasal protocol, expected cognitive effects, and combination with Semax.
Pentosan Polysulfate for Joint Cartilage Preservation
A representative use case for pentosan polysulfate (PPS) in joint cartilage preservation — osteoarthritis management, dosing protocol, combination with BPC-157, and realistic expectations.
5-Amino-1MQ for Metabolic Enhancement
A representative use case for 5-Amino-1MQ in metabolic rate enhancement and fat cell regulation — NNMT inhibition mechanism, oral protocol, and the significant gap between in vitro promise and clinical unknowns.
Cerebrolysin for Neuroregeneration
A representative use case for cerebrolysin in post-stroke recovery and neurodegenerative cognitive decline — neurotrophic peptide mixture, intramuscular protocol, and the Western vs. international evidence divide.
Dihexa for Age-Related Cognitive Decline
A representative use case for dihexa in age-related cognitive decline — HGF/c-Met pathway mechanism, oral bioavailability advantage, and the wide gap between extraordinary preclinical potency and absent human data.
FOXO4-DRI for Senescent Cell Clearance
A representative use case for FOXO4-DRI as a peptide senolytic — disrupting the FOXO4-p53 interaction to selectively clear senescent cells, with a frank assessment of the preclinical-only evidence base.
Gonadorelin for HPT Axis Support
A representative use case for gonadorelin in hypothalamic-pituitary-testicular axis support — maintaining gonadal function during TRT or GH-secretagogue protocols.
Humanin for Cellular Protection
A representative use case for humanin in age-related cellular protection — mitochondrial-derived cytoprotective peptide, its role against apoptosis and metabolic stress, and the purely preclinical evidence landscape.
Retatrutide for Metabolic Syndrome
A representative use case for retatrutide in metabolic syndrome — the first triple incretin agonist (GLP-1/GIP/glucagon) with phase 2 data showing up to 24% weight loss and simultaneous metabolic improvements.
SS-31 (Elamipretide) for Mitochondrial Aging
A representative use case for SS-31 in age-related mitochondrial dysfunction — cardiolipin stabilization, exercise capacity restoration, and the gap between compelling preclinical data and limited clinical validation.
Tesamorelin for Visceral Fat Reduction
A representative use case for tesamorelin in visceral adipose tissue reduction — the only GHRH analog with FDA approval and RCT evidence for compartment-specific fat loss.
Tirzepatide for Weight Management
A representative use case for tirzepatide in obesity and overweight management — dual GLP-1/GIP mechanism, dose escalation protocol, body composition considerations, and realistic timeline.
AOD-9604 for Body Recomposition
A representative use case for AOD-9604 in visceral fat reduction and body recomposition — subcutaneous abdominal protocol, 12-week timeline, and differentiation from full-length GH.
DSIP for Chronic Insomnia & Sleep Quality
A representative use case for delta sleep-inducing peptide (DSIP) in sleep-onset insomnia and disrupted sleep architecture — subcutaneous protocol, expected timeline, and combination considerations.
Follistatin-344 for Muscle Preservation
A representative use case for follistatin-344 in muscle wasting prevention and lean mass preservation — research context, short-cycle protocol, and the current evidence landscape.
GHK-Cu for Topical Wound & Skin Healing
A representative use case for GHK-Cu in post-procedure healing, chronic wound care, and scar remodeling — topical protocol, concentration guidance, expected timeline, and monitoring.
Hexarelin for Growth Hormone Pulsatile Release
A representative use case for hexarelin in maximizing GH pulse amplitude — subcutaneous protocol, desensitization management at 4 weeks, and comparison with other GHRPs.
Sermorelin for Age-Related GH Decline
A representative use case for sermorelin in adults 40+ experiencing age-related GH/IGF-1 decline — subcutaneous protocol, 5-on-2-off schedule, 3-6 month commitment, and combination with ipamorelin.
Ipamorelin for Sleep Optimization
A representative use case for ipamorelin to improve sleep quality — leveraging the GH-sleep relationship, bedtime dosing strategy, and objective monitoring.
LL-37 for Chronic and Biofilm-Associated Infections
A representative use case for LL-37 in chronic infections — targeting biofilm disruption, antimicrobial defense, and immune modulation for persistent infections unresponsive to antibiotics.
MOTS-c for Exercise Performance and Metabolic Fitness
A representative use case for MOTS-c in exercise performance — enhancing metabolic flexibility, glucose utilization, and mitochondrial function during training.
Thymosin Alpha-1 for Long COVID Immune Dysregulation
A representative use case for thymosin alpha-1 in long COVID — targeting persistent immune dysregulation, T-cell exhaustion, and chronic inflammation with an immunomodulatory approach.
VIP for Respiratory and Pulmonary Health
A representative use case for vasoactive intestinal peptide (VIP) in respiratory conditions — CIRS, pulmonary inflammation, and biotoxin-related airway dysfunction.
Semax for Cognitive Enhancement & Neuroprotection
A representative use case for Semax in cognitive enhancement — intranasal BDNF upregulation, protocol design for focus and memory, combination with Selank, and realistic expectations.
Thymosin Alpha-1 for Immune Defense & T-Cell Function
A representative use case for Thymosin Alpha-1 in immune enhancement — T-cell modulation, clinical protocol design for chronic infections and immunosenescence, and what the clinical evidence actually supports.
Epitalon for Longevity & Telomere Support
A representative use case for Epitalon in longevity and telomere maintenance — cycled subcutaneous protocol, telomerase activation rationale, and realistic expectations from Khavinson's research.
KPV for Gut Inflammation & Intestinal Health
A representative use case for KPV in gut inflammation, intestinal barrier repair, and IBD symptom management — oral protocol, NF-κB inhibition mechanism, and realistic evidence assessment.
MOTS-c for Metabolic Health & Insulin Sensitivity
A representative use case for MOTS-c in metabolic syndrome, insulin resistance, and body composition — AMPK activation rationale, subcutaneous protocol, and expected metabolic markers.
Selank for Anxiety & Stress Reduction
A representative use case for Selank in anxiety and chronic stress management — intranasal protocol, GABA modulation rationale, expected timeline, and combination with Semax.
TB-500 for Muscle Injury Recovery
A representative use case for TB-500 in muscle strain and tear recovery — loading protocol, actin-sequestration mechanism, expected milestones, and combination with BPC-157.
BPC-157 for Tendon & Ligament Recovery
A representative use case for BPC-157 in tendon and ligament recovery — injury assessment, protocol design, timeline expectations, and when to add TB-500.
CJC-1295/Ipamorelin for Sleep & Recovery
A representative use case for CJC-1295/Ipamorelin targeting nocturnal GH pulsatility for improved sleep quality and training recovery.
PT-141 for Sexual Wellness
A representative use case for PT-141 (bremelanotide) targeting central libido pathways — mechanism, dosing, timing relative to activity, and realistic expectations.
Semaglutide for Weight Management
A representative use case for semaglutide in long-term weight management — dose titration, lean mass preservation, lifestyle integration, and realistic outcome expectations.
GHK-Cu for Skin Rejuvenation
A representative use case for topical GHK-Cu in skin rejuvenation — product selection, routine integration, expected timeline, and combination with complementary actives.
Peptides for Post-Surgery Recovery
A representative use case for healing peptides in post-surgical recovery — BPC-157 and TB-500 protocols, timing considerations, and monitoring framework.
GLP-1 Agonists for Chronic Weight Management
A representative use case for GLP-1 receptor agonists in chronic weight management — candidate profile, protocol, expected trajectory, and monitoring.